Investors & Media

The investor relations section of Selvita S.A. is addressed to all capital market participants and media, and in particular to our shareholders, analysts, individual and institutional investors interested in our company.

You’ll be able to find here the latest information on our financial results, current operations and development plans, as well as a range of other useful information. If there is anything more you should need, don’t hesitate to contact us!

Investors & Media

Overview

Selvita share price [PLN]

News feed

Selvita's Capabilities In Antiviral Drug Discovery
02 April 2020

Selvita's Capabilities In Antiviral Drug Discovery

Continue reading
Selvita 2019 financial results: accelerated growth, 43 percent increase in commercial revenues and a very solid backlog for 2020
26 March 2020

Selvita 2019 financial results: accelerated growth, 43 percent increase in commercial revenues and a very solid backlog for 2020

Continue reading
Update on Selvita current situation and how COVID-19 influences our daily activities
20 March 2020

Update on Selvita current situation and how COVID-19 influences our daily activities

Continue reading

Reports

Show
  • 26 March 2020

    Report ESPI – RS 2019

    Selvita Group Consolidated Annual Report (Summary) 2019
  • 07 November 2019

    Raport ESPI SA-Q 3/2019

    Selvita S.A. Quarterly Report 2019 Q3 (Summary)

Financial results

PLN 55 356 022 73 233 124 76 702 381 105 238 215
PLN 7 769 051 8 325 269 11 013 897 13 965 572
PLN 11 286 217 16 487 113 15 999 139 24 757 235
PLN 8 276 192 7 981 042 11 377 433 14 040 376

* Presented data show the financial results achieved by the Separated Part (CRO) in the period from 01/01/2018 to 30/09/2018 and demonstrate how the Selvita S.A. Group financial data would look like if the corporate split had happened on January 1, 2018.

* Presented data show the financial results achieved by the Separated Part (CRO) in the period from 01/01/2019 to 30/09/2019 and demonstrate how the Selvita S.A. Group financial data would look like if the corporate split had happened on January 1, 2018.

** Presented data show the financial results achieved by the Separated Part (CRO) in the period from 01/01/2018 to 31/12/2018 and demonstrate how the Selvita S.A. Group financial data would look like if the corporate split had happened on January 1, 2018.

** Presented data show the financial results achieved by the Separated Part (CRO) in the period from 01/01/2019 to 31/12/2019 and demonstrate how the Selvita S.A. Group financial data would look like if the corporate split had happened on January 1, 2018.

*** Revenues from sales + revenues from grants + remaining operating revenues

Shareholder structure

Share in capital
Share in votes
Shareholder Share in capital Share in votes
Paweł Przewięźlikowski
Bogusław Sieczkowski
Augebit FIZ*
Nationale Nederlanden OFE
Remaining Management Board and Supervisory Board Members
Remaining Shareholders
* the beneficiary of Augebit FIZ is Tadeusz Wesołowski – Vice Chairman of Selvita Supervisory Board; information based on the number of shares from the last notification provided by the shareholder to the Company (without taking into account the dilution resulting from the issue of H shares).
selvita_logo

Contacts